BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18590648)

  • 1. [Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy].
    Alegría Ezquerra E; Castellano Vázquez JM; Alegría Barrero A
    Rev Esp Cardiol; 2008 Jul; 61(7):752-64. PubMed ID: 18590648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL
    Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple risk factors for cardiovascular disease and diabetes mellitus.
    Smith SC
    Am J Med; 2007 Mar; 120(3 Suppl 1):S3-S11. PubMed ID: 17320520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
    Strobl DJ
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S21-2. PubMed ID: 19451255
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of obesity and cardiovascular risk factors in a group of paediatric patients with type 1 diabetes].
    Palomo Atance E; Giralt Muiña P; Ballester Herrera MJ; Ruiz Cano R; León Martín A; Giralt Muiña J
    An Pediatr (Barc); 2013 Jun; 78(6):382-8. PubMed ID: 23273627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic Syndrome: clinical and pathophysiological basis for a rational therapeutical approach].
    Martínez R G; Alonso K R; Novik A V
    Rev Med Chil; 2009 May; 137(5):685-94. PubMed ID: 19701560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolic syndrome as related to cardiovascular disease.
    Nikolopoulou A; Kadoglou NP
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome.
    Garber AJ
    Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.